BRIEF published on 10/01/2025 at 08:05, 2 months 3 days ago SSE PLC Reports Total Voting Rights Share Capital Voting Rights Transparency FCA Guidance SSE PLC
PRESS RELEASE published on 10/01/2025 at 08:00, 2 months 3 days ago Total Voting Rights SSE PLC announces total voting rights as of 30th September 2025 in compliance with FCA rules Total Voting Rights FCA Rules SSE PLC
BRIEF published on 09/01/2025 at 08:05, 3 months 3 days ago SSE PLC Updates on Voting Rights and Capital Structure Share Capital Voting Rights Regulatory Compliance Treasury Shares SSE PLC
PRESS RELEASE published on 09/01/2025 at 08:00, 3 months 3 days ago TVR-Total Voting Rights SSE PLC notifies the market of the total voting rights as of 1 September 2025, totaling 1,106,553,868. Shareholders can use this figure for disclosure obligations Share Capital Voting Rights Disclosure Transparency SSE PLC
Published on 12/05/2025 at 02:35, 5 hours 6 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 41 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 36 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 41 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 41 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 11 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 50 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 16 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 26 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 41 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 56 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 57 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
